Examining Gender as a Sociocultural Variable Shaping Health Outcomes of Cancer Caregiving

检查性别作为影响癌症护理健康结果的社会文化变量

基本信息

  • 批准号:
    10770121
  • 负责人:
  • 金额:
    $ 16.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-19 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT With advances in early detection and novel, targeted cancer treatments, a growing number of individuals provide support for cancer survivors who have completed curative intent therapy (“curvivors”) as well as for those who live for many years with metastatic disease (“metavivors”). Cancer caregiving relationships for curvivors and metavivors alike are associated with high stress, particularly as individuals transition to post- initial treatment survivorship and experience decreased contact with medical providers, continued need for medical symptom monitoring, and evolution in relationship dynamics between caregiver and care recipient. As such, caregivers (partners, family members, close friends) may struggle with unmet needs for their own well- being and healthcare utilization (e.g., attendance at follow-up visits, routine healthcare screenings) while supporting the survivor they care for. Though caregiving roles are disproportionately held by women, little is known about possible gender differences in the health impact of cancer caregiving stress during the transition to post-initial treatment survivorship. No existing interventions provide concurrent but separate support for cancer survivors and caregivers at this critical transition point; as such, the parent R21 (“Building Resiliency Among Caregivers of Curvivors and Metavivors: A Pilot Randomized Trial,” R21 CA273785-01) is highly novel in its aim to evaluate the feasibility, acceptability, and preliminary efficacy of the Stress Management and Resiliency Training-Relaxation Resiliency Response Program (SMART-3RP) as delivered concurrently to separate groups of cancer caregivers and survivors. Building upon the aims of the parent grant, this Administrative Supplement (in response to NOT-OD-22-030) will explicate key indices of feasibility and acceptability by participant gender. Leveraging quantitative self-report and biobehavioral (i.e., hair cortisol) data from 48 cancer caregiver-survivor dyads (N = 96), we will also analyze gender differences in baseline characteristics mapping onto gender as a sociocultural variable (i.e., gender norms, gender-related traits, and gender relations), as well as gender differences in preliminary efficacy of the SMART-3RP for caregivers’ and survivors’ resiliency (primary) and healthcare utilization (secondary). To enrich interpretation of quantitative analyses, we will add 3 questions to the planned qualitative exit interviews, regarding of sociocultural aspects of gender in cancer caregiving. This Administrative Supplement will provide timely support for the research team to meaningfully generate empirical mixed-methods data regarding gender differences in intervention feasibility, acceptability, and preliminary efficacy and promote health equity for women in the growing landscape of cancer caregiving research. Further, this work will provide a critical opportunity for MPIs Park and El-Jawahri to support Dr. Lucy Finkelstein-Fox, a promising junior investigator mentored by Drs. Park and El- Jawahri whose research program is dedicated to women’s health and intimacy in cancer survivorship.
项目摘要/摘要 随着早期发现和新的靶向癌症治疗方法的进步,越来越多的人 为已完成治疗性意向治疗的癌症幸存者(“Curvivors”)以及 那些带着转移性疾病生活多年的人(“后生动物”)。癌症护理关系 Curvivors和Metavivors同样与高压力有关,特别是当个体过渡到后 初步治疗存活率和经验减少了与医疗提供者的接触,继续需要 医疗症状监测,以及照顾者和受照者之间关系动态的演变。AS 这样的照顾者(合作伙伴、家庭成员、亲密朋友)可能会为自己的福祉而挣扎于未得到满足的需求- 和医疗保健利用(例如,参加后续访问、例行医疗保健筛查) 支持他们所关心的幸存者。尽管照看角色由女性担任的比例不成比例,但几乎没有 已知过渡期癌症护理压力对健康影响的性别差异 到初步治疗后的存活率。没有现有的干预措施同时但单独地支持 处于这一关键转折点的癌症幸存者和照顾者;因此,父母R21(建立弹性 在Curvivors和Metavivors的照顾者中:试点随机试验,R21 CA273785-01)是非常新颖的 其目的是评估压力管理的可行性、可接受性和初步效果 弹性培训-松弛弹性响应计划(SMART-3RP),同时提供给 癌症护理人员和幸存者分别组成不同的小组。在母公司赠款目标的基础上,这 行政补编(针对NOT-OD-22-030)将详细说明可行性和 按参与者性别划分的可接受性。利用量化自我报告和生物行为(如头发皮质醇) 来自48名癌症照顾者-幸存者二人组(N=96)的数据,我们还将分析基线中的性别差异 将性别映射为社会文化变量的特征(即性别规范、与性别有关的特征和 性别关系),以及SMART-3RP对照顾者的初步疗效的性别差异 幸存者的复原力(主要)和医疗保健利用率(次要)。要丰富对数量的解读 分析,我们将在计划的定性离职面试中增加3个问题,涉及社会文化方面 在癌症护理中的性别。本行政副刊将为研究提供及时的支持 团队将有意义地生成关于干预中性别差异的经验混合方法数据 可行性、可接受性和初步有效性,并促进妇女健康公平的增长 癌症护理研究的现状。此外,这项工作将为MPIS Park和 El-Jwahri支持Lucy Finkelstein-Fox博士,一位有前途的初级调查员,由Park博士和El-Jwahri博士指导- 贾瓦赫里的研究项目致力于女性在癌症生存中的健康和亲密关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Areej El-Jawahri其他文献

Areej El-Jawahri的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Areej El-Jawahri', 18)}}的其他基金

Building Resiliency Among Caregivers of Curvivors and Metavivors: A Pilot randomized Trial
建立幸存者和元幸存者的照顾者的复原力:一项随机试点试验
  • 批准号:
    10509455
  • 财政年份:
    2022
  • 资助金额:
    $ 16.56万
  • 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
  • 批准号:
    10028263
  • 财政年份:
    2020
  • 资助金额:
    $ 16.56万
  • 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
  • 批准号:
    10636846
  • 财政年份:
    2020
  • 资助金额:
    $ 16.56万
  • 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
  • 批准号:
    10252907
  • 财政年份:
    2020
  • 资助金额:
    $ 16.56万
  • 项目类别:
Randomized Trial of a Home-Advance Care Planning Video Intervention for Patients with Life-limiting Illness
针对生命有限疾病患者的家庭预先护理计划视频干预的随机试验
  • 批准号:
    10412118
  • 财政年份:
    2020
  • 资助金额:
    $ 16.56万
  • 项目类别:
Multimodal Mobile Intervention Application (app) to Address Symptoms in Hematopoietic Stem Cell Transplant Survivors
用于解决造血干细胞移植幸存者症状的多模式移动干预应用程序 (app)
  • 批准号:
    10000145
  • 财政年份:
    2019
  • 资助金额:
    $ 16.56万
  • 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
  • 批准号:
    9980805
  • 财政年份:
    2018
  • 资助金额:
    $ 16.56万
  • 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
  • 批准号:
    10456762
  • 财政年份:
    2018
  • 资助金额:
    $ 16.56万
  • 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
  • 批准号:
    10222595
  • 财政年份:
    2018
  • 资助金额:
    $ 16.56万
  • 项目类别:
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
接受造血干细胞移植的血液恶性肿瘤患者住院姑息治疗的随机试验
  • 批准号:
    9761504
  • 财政年份:
    2018
  • 资助金额:
    $ 16.56万
  • 项目类别:

相似海外基金

Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
  • 批准号:
    10806365
  • 财政年份:
    2023
  • 资助金额:
    $ 16.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了